Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

B of A Securities Analyst Initiates Coverage on Merit Medical Systems with Neutral Rating and 87 Price Target

Elaine Mendonca by Elaine Mendonca
February 7, 2024
in Breaking News
0
Navigating Legal Battles: A Deep Dive into High-Stakes Cryptocurrency Disputes
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On February 7, 2024, Craig Bijou, an analyst at B of A Securities, has started covering Merit Medical Systems (NASDAQ:MMSI) and has given it a Neutral rating. He has also revealed a Price Target of $87 for the stock. This signifies that the analyst holds a balanced viewpoint, neither too optimistic nor pessimistic, regarding the stock’s future performance. The $87 Price Target serves as a benchmark, indicating the analyst’s belief that the stock is fairly valued at this level. This valuable information offers valuable insights to investors and market participants who are closely monitoring Merit Medical Systems’ stock.

MMSI Stock Shows Steady Performance and Potential for Growth in 2024

On February 7, 2024, MMSI stock showed a steady performance, trading in the middle of its 52-week range and above its 200-day simple moving average. The stock closed at $78.62, representing a slight increase of $0.26 or 0.33% since the market last closed.

MMSI’s position in the middle of its 52-week range suggests stability and consistency in its performance.

Trading above its 200-day moving average indicates a long-term upward trend for MMSI.

The modest price increase on February 7, 2024, shows positive movement in the stock’s value.

The lack of significant price changes in after-hours trading suggests no major news or events impacting the stock’s performance.

Overall, MMSI stock demonstrated stability, potential for growth, and may be an attractive option for investors.

Stable Performance and Impressive Financial Results: MMSI Stock Analysis for February 7, 2024

MMSI stock demonstrated a stable performance on February 7, 2024, reflecting the company’s consistent revenue growth and increasing net income. MMSI’s total revenue for the past year amounted to $1.15 billion, showing a 6.21% increase compared to the previous year. The company’s net income also witnessed significant growth over the past year, with a net income of $74.52 million, reflecting a remarkable 53.79% increase compared to the previous year. MMSI’s EPS for the past year stood at $1.29, indicating a substantial increase of 52.95% compared to the previous year. Overall, MMSI’s stock performance on February 7, 2024, was positive, reflecting the company’s impressive financial results. Investors and analysts are likely to view MMSI as a promising investment opportunity, considering its consistent revenue growth, increasing net income, and rising earnings per share. However, further research and analysis are recommended before making any investment decisions.

Tags: MMSI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Investing

Jefferies Analyst Initiates Coverage on ZoomInfo Technologies with a Buy Rating and 20 Price Target

Finance_Investment (5)

Financial Analysts Express Optimism for Civitas Resources Stock Performance

Energy Company Markets and money

RBio Energy Corporations Transformative Journey Becoming a Publicly Traded Company

Recommended

Transportation Stock Bull Market

JR Kyushu Implements AIPowered AMD Kria K26 SOM for Enhanced Track Inspection Efficiency and Safety

2 years ago
TMUS stock news

Wedbush Analyst Maintains Outperform Rating and Raises Price Target for Global Payments

2 years ago
JD.com Stock

JD.com Shares Surge on Robust Performance and Strategic Moves

3 months ago
Mobile-handsets

Palantir Technologies Reveals Revenue Projections for Q1 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Nvidia Accelerates AI Dominance with Early Chip Launch and Strategic Expansions

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

Marvell Technology Shares Face Conflicting Market Cues

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

by Felix Baarz
January 11, 2026
0

The shares of Viking Therapeutics, a biotechnology firm, are presenting investors with a conflicting narrative this week....

Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026
Realty Income Stock

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

January 11, 2026
Procter & Gamble Stock

Procter & Gamble Shares Approach a Critical Juncture

January 11, 2026
Vital Farms Stock

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: A Tale of Clinical Progress and Insider Selling
  • Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals
  • Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com